Olema Pharmaceuticals, Inc. (OLMA) updates 13D/A
- BVF owns 5,946,981 shares (6.6%)
- BVF2 owns 2,356,800 shares (2.7%)
- Trading Fund OS owns 347,970 shares
BIOTECHNOLOGY VALUE FUND L P, filed by
OLMA
Olema Pharmaceuticals, Inc. SEC filings
Every EDGAR filing for Olema Pharmaceuticals, Inc. (OLMA), newest first, with AI summaries and stories.
- Ticker
- OLMA
- CIK
- 1750284
- Sector
- Biotech and pharma
- Latest filing
- 2d
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
NOTABLESCHEDULE 13D/AOlema Pharmaceuticals, Inc.OLMALIVE MAJOR8-KOlema Pharmaceuticals, Inc.OLMALIVE Olema Pharmaceuticals reports director changes
- Dr. Gorjan Hrustanovic resigned from Olema's Board on 10/14/2026
- Dr. Hrustanovic left Compensation and Science committees
- Dr. Prakash Raman joined Compensation and Science committees on 10/15/2026
ROUTINE4Olema Pharmaceuticals, Inc.OLMALIVE Jason O'Byrne, insider filing for OLMA
Jason O'Byrne, reporting
ROUTINE3Olema Pharmaceuticals, Inc.OLMALIVE Jason O'Byrne, new insider at OLMA
Jason O'Byrne, reporting
ROUTINE8-KOlema Pharmaceuticals, Inc.OLMALIVE NOTABLE10-QOlema Pharmaceuticals, Inc.OLMALIVE ROUTINE8-KOlema Pharmaceuticals, Inc.OLMALIVE ROUTINESCHEDULE 13G/AOlema Pharmaceuticals, Inc.OLMALIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
ROUTINESCHEDULE 13G/AOlema Pharmaceuticals, Inc.OLMALIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
ROUTINE4Olema Pharmaceuticals, Inc.OLMALIVE Cyrus Harmon, insider filing for OLMA
Cyrus Harmon, reporting
ROUTINE144Olema Pharmaceuticals, Inc.OLMALIVE Cyrus Harmon, planned sale of OLMA shares
Cyrus Harmon, reporting
ROUTINE144Olema Pharmaceuticals, Inc.OLMALIVE Cyrus Harmon, planned sale of OLMA shares
Cyrus Harmon, reporting
ROUTINE4Olema Pharmaceuticals, Inc.OLMALIVE 11 insider filings
BIOTECHNOLOGY VALUE FUND L P, insider filing for OLMA
Show all 11
- 4Insider filing for OLMA
- 4Insider filing for OLMA
- 4Insider filing for OLMA
- 4Insider filing for OLMA
- 4Insider filing for OLMA
- 4Insider filing for OLMA
- 4Insider filing for OLMA
- 4Insider filing for OLMA
- 4Insider filing for OLMA
- 4Insider filing for OLMA
- 4Insider filing for OLMA
BIOTECHNOLOGY VALUE FUND L P, reporting · BVF PARTNERS L P/IL, reporting · +8 more
ROUTINE8-KOlema Pharmaceuticals, Inc.OLMALIVE ROUTINE8-KOlema Pharmaceuticals, Inc.OLMALIVE ROUTINE8-KOlema Pharmaceuticals, Inc.OLMALIVE ROUTINESCHEDULE 13G/AOlema Pharmaceuticals, Inc.OLMALIVE Ownership stake disclosure by Bain Capital Life Sciences Opportunities IV, L.P. (amended)
Bain Capital Life Sciences Opportunities IV, L.P., filed by
ROUTINESCHEDULE 13G/AOlema Pharmaceuticals, Inc.OLMALIVE Ownership stake disclosure by JANUS HENDERSON GROUP PLC (amended)
JANUS HENDERSON GROUP PLC, filed by
NOTABLE10-QOlema Pharmaceuticals, Inc.OLMALIVE ROUTINE8-KOlema Pharmaceuticals, Inc.OLMALIVE ROUTINE8-KOlema Pharmaceuticals, Inc.OLMALIVE ROUTINE4Olema Pharmaceuticals, Inc.OLMALIVE Prakash Raman, insider filing for OLMA
Prakash Raman, reporting
ROUTINE3Olema Pharmaceuticals, Inc.OLMALIVE Prakash Raman, new insider at OLMA
Prakash Raman, reporting
ROUTINEDEF 14AOlema Pharmaceuticals, Inc.OLMALIVE ROUTINEDEFA14AOlema Pharmaceuticals, Inc.OLMALIVE ROUTINEARSOlema Pharmaceuticals, Inc.OLMALIVE ROUTINE8-KOlema Pharmaceuticals, Inc.OLMALIVE ROUTINESCHEDULE 13GOlema Pharmaceuticals, Inc.OLMALIVE Ownership stake disclosure by Invus Global Management, LLC
Invus Global Management, LLC, filed by
ROUTINE144Olema Pharmaceuticals, Inc.OLMALIVE Shane William Charles Kovacs, planned sale of OLMA shares
Shane William Charles Kovacs, reporting
ROUTINE144Olema Pharmaceuticals, Inc.OLMALIVE Shane William Charles Kovacs, planned sale of OLMA shares
Shane William Charles Kovacs, reporting
ROUTINES-8Olema Pharmaceuticals, Inc.OLMALIVE NOTABLE10-KOlema Pharmaceuticals, Inc.OLMALIVE ROUTINE8-KOlema Pharmaceuticals, Inc.OLMALIVE ROUTINE144Olema Pharmaceuticals, Inc.OLMALIVE Shane William Charles Kovacs, planned sale of OLMA shares
Shane William Charles Kovacs, reporting
ROUTINE144Olema Pharmaceuticals, Inc.OLMALIVE Shane William Charles Kovacs, planned sale of OLMA shares
Shane William Charles Kovacs, reporting
ROUTINE144Olema Pharmaceuticals, Inc.OLMALIVE Shane William Charles Kovacs, planned sale of OLMA shares
Shane William Charles Kovacs, reporting
ROUTINESCHEDULE 13G/AOlema Pharmaceuticals, Inc.OLMALIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
ROUTINE4Olema Pharmaceuticals, Inc.OLMALIVE Shawnte Mitchell, insider filing for OLMA
Shawnte Mitchell, reporting
ROUTINE144Olema Pharmaceuticals, Inc.OLMALIVE Shane William Charles Kovacs, planned sale of OLMA shares
Shane William Charles Kovacs, reporting
ROUTINE144Olema Pharmaceuticals, Inc.OLMALIVE Shawnte Mitchell, planned sale of OLMA shares
Shawnte Mitchell, reporting